Last updated 2026-07-20
- Acquired by FIMI Opportunity Funds for $200M, Oct 2020
- Raised $135M IPO led by FIMI Opportunity Funds, Jul 2026
- Raised $186M grant, Nov 2025
Total raised
$601.0M
Stage
Acquired
Founded
1937
Headcount
260
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
Rafa Laboratories is a leading Israeli pharmaceutical company, founded in 1937, specializing in the manufacturing, marketing, and distribution of prescription and over-the-counter medicines. The company is committed to providing high therapeutic value products and has a strong focus on partnerships and innovation in the healthcare sector. Rafa also operates as a global leader in biodefense and emergency medical solutions, supplying medical countermeasure autoinjectors to government agencies, military forces, and civilian stockpiles worldwide. Their expertise spans the entire value chain from R&D to cGMP-compliant manufacturing and regulatory approvals.
Funding history · 6 rounds · $601.0M total
2026-07
IPO
$135.0M
★ FIMI Opportunity FundsPublic investors
2026-06
Grant
$46.0M
★ U.S. Department of Health and Human Services (HHS)Strategic National Stockpile (SNS)
2025-11
Grant
$186.0M
U.S. Department of Health and Human Services
2023-02
Grant
$45.0M
★ U.S. Department of Defense
2022-08
Undisclosed Round
Undisclosed
★ ExCEEd Orphan
2020-10
Secondary
$189.0M
★ FIMI Opportunity Funds
Q&A
- When was Rafa Laboratories founded?
- Rafa Laboratories was established in 1937.
- What is Rafa Laboratories' primary business focus?
- Rafa Laboratories is a leading Israeli pharmaceutical company specializing in manufacturing, marketing, and distributing prescription and over-the-counter medicines, as well as consumer health products. It also operates globally in emergency medical solutions and biodefense.
- How many employees does Rafa Laboratories have?
- Rafa Laboratories has 260 employees, falling within the 201-500 employee bucket.
- Who acquired Rafa Laboratories and for what amount?
- In October 2020, Rafa Laboratories was acquired by FIMI Opportunity Funds for $206,000,000.
- What is the total amount of funding Rafa Laboratories has raised?
- Rafa Laboratories has raised a total of $206,000,000 through its funding rounds.
- Who is the CEO of Rafa Laboratories?
- Iddo Leshem is the CEO of Rafa Laboratories.
- What is an example of an investment made by Rafa Laboratories?
- In August 2022, Rafa Laboratories made a buyout/LBO investment in ExCEEd Orphan.
- Who is the Chairperson of Rafa Laboratories' board?
- Ori Yehudai serves as the Chairperson of Rafa Laboratories' board.
Team · 8
Dr. Baruch Samuel Levin
Founder · Founder
Iddo Leshem
CEO
Yael Tomer
VP, Regulatory Affairs, Pharmacovigilance, Medical Information
Gabi Hazan
Plant Manager Director
Liraz Levi
executives
Roy Shay
VP, Biodefense
Ori Yehudai
Chairperson
Amir Levin
Vice Chairman
Sectors & technology
Primary sector
Health Tech & Life Sciences
Target customers
Business model
B2BB2GB2C
Highlights
Patents
Tags
pharmaceuticalsbiotechnologyhealth-techmanufacturingprescription-medicinesover-the-counter-medicinesbiodefenseemergency-medical-solutions
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | rafa.co.il |
|---|---|
| Wikipedia | he.wikipedia.org/wiki/%D7%9E%D7%A2%D7%91%D7%93%D7%95%D7%AA_% |
| Wikidata | wikidata.org/wiki/Q25489834 |
Identifiers & details
| Legal name | Rafa Laboratories Ltd. |
|---|---|
| Founded | 1937 |
| Employees (exact) | 260 |
| Wikidata QID | Q25489834 |
Acquisitions & public offerings
Acquired by FIMI Opportunity Funds 2020-10 $200.0M
Radar intelligence
Patents
| EPO | 18 |
|---|
Web history (Wayback)
| Domain | rafa.co.il |
|---|
Wikidata
| QID | Q25489834 |
|---|
Certificate / subdomain footprint
| Subdomains | 14 |
|---|